| Evolution of Janus Kinase inhibitors (JAKi) prescriptions since 2015 in an international collaboration of rheumatoid arthritis registers (the 'JAK-pot' study) : effect of regulatory warnings | Seminars in arthritis and rheumatism | | | 2026 | 7 | 11 |
|
| Site-specific articular responses to b/tsDMARDs in rheumatoid arthritis : a longitudinal observational study from the Swiss Clinical Quality Management Registry | RMD open | | | 2026 | 7 | 10 |
|
| Influence of the shared epitope on the effectiveness of biologic antirheumatic agents in European patients with rheumatoid arthritis | RMD open | | | 2026 | 6 | 12 |
|
| Machine Learning to Predict Remission Between 6 and 24 Months in Rheumatoid Arthritis : Insights From JAK, an International Registry Collaboration | Arthritis & rheumatology | | | 2026 | 6 | 11 |
|
| Rhumatismes inflammatoires : où en est-on avec les JAK-inhibiteurs ? | Rheuma Plus / Schweiz | | | 2025 | 18 | 136 |
|
| Identification of individuals at high risk of developing rheumatoid arthritis : a balanced random forest model in a cohort of 1544 first-degree relatives | RMD open | | | 2025 | 26 | 85 |
|
| Reply | Arthritis & rheumatology | | | 2025 | 31 | 0 |
|
| Antibiotics in inflammatory arthritis and background population one year before and after diagnosis : a nationwide drug utilization study | Rheumatology | | | 2025 | 20 | 17 |
|
| When borders impact science : what is the future of European rheumatology research ? | Annals of the rheumatic diseases | | | 2025 | 11 | 0 |
|
| Incidence of major adverse cardiovascular events in patients with rheumatoid arthritis treated with Janus kinase inhibitors compared to biologic disease-modifying antirheumatic drugs : data from an international collaboration of registries (the "JAK-pot" study) | Arthritis & rheumatology | | | 2025 | 97 | 171 |
|
| Antirheumatic drugs in reproduction, pregnancy, and lactation : a systematic literature review informing the 2024 update of the EULAR recommendations | Annals of the rheumatic diseases | | | 2025 | 26 | 1,156 |
|
| The epidemiology of RA | Nature reviews. Rheumatology | | | 2025 | 13 | 0 |
|
| Systematic literature review and meta-analysis informing the EULAR points to consider on the initiation of targeted therapies in patients with inflammatory arthritis and a history of cancer | Annals of the rheumatic diseases | | | 2025 | 57 | 0 |
|
| Rhumatologie : ce qui a changé en 2023 | Revue médicale suisse | | | 2024 | 62 | 69 |
|
| Comparative effectiveness of biologics in patients with rheumatoid arthritis stratified by body mass index : a cohort study in a Swiss registry | BMJ open | | | 2024 | 18 | 38 |
|
| Rotation or change of biotherapy after TNF blocker treatment failure for axial spondyloarthritis : the ROC-SpA study, a randomised controlled study protocol | BMJ open | | | 2024 | 16 | 182 |
|
| Anti-Apolipoprotein A-1 IgG, incident cardiovascular events and lipid paradox inrheumatoid arthritis | ESC (Europan Society of Cardiology) Congress 2024 | | | 2024 | 11 | 0 |
|
| Gut microbiome and intestinal inflammation in preclinical stages of rheumatoid arthritis | RMD open | | | 2024 | 115 | 97 |
|
| Anti-apolipoprotein A-1 IgG, incident cardiovascular events and lipid paradox in rheumatoid arthritis | 92nd EAS (European Atherosclerosis Society) Congress | | | 2024 | 20 | 0 |
|
| Evaluation of discontinuation for adverse events of JAK inhibitors and bDMARDs in an international collaboration of rheumatoid arthritis registers (the ‘JAK-pot’ study) | Annals of the rheumatic diseases | | | 2024 | 105 | 96 |
|
| Explainable deep learning for disease activity prediction in chronic inflammatory joint diseases | PLOS digital health | | | 2024 | 13 | 33 |
|
| Anti-apolipoprotein A-1 IgG, incident cardiovascular events, and lipid paradox in rheumatoid arthritis | Frontiers in cardiovascular medicine | | | 2024 | 126 | 281 |
|
| Comparative effectiveness of baricitinib and alternative biological DMARDs in a Swiss cohort study of patients with RA | BMJ open | | | 2024 | 143 | 141 |
|
| Tofacitinib Monotherapy in Rheumatoid Arthritis : Clinical Trials and Real-World Data Contextualization of Patients, Efficacy, and Treatment Retention | Open access rheumatology | | | 2024 | 15 | 23 |
|
| Oral glucocorticoid use in patients with rheumatoid arthritis initiating TNF-inhibitors, tocilizumab or abatacept: Results from the international TOCERRA and PANABA observational collaborative studies | Joint bone spine | | | 2024 | 109 | 162 |
|
| 2024 EULAR points to consider on the initiation of targeted therapies in patients with inflammatory arthritis and a history of cancer | Annals of the rheumatic diseases | | | 2024 | 76 | 3,135 |
|
| Concomitant Sjögren's disease as a biomarker for treatment effectiveness in rheumatoid arthritis - results from the Swiss clinical quality management cohort | Arthritis research & therapy | | | 2024 | 15 | 90 |
|
| Brief report: can COVID-19 infection trigger rheumatoid arthritis-associated autoimmunity in individuals at risk for the disease? A nested cohort study | Frontiers in medicine | | | 2023 | 74 | 118 |
|
| Longitudinal associations between body mass index and changes in disease activity and radiographic progression in rheumatoid arthritis patients treated with infliximab | RMD open | | | 2023 | 91 | 48 |
|
| The Symptoms in Persons At Risk of Rheumatoid Arthritis (SPARRA) questionnaire: predicting clinical arthritis development | Scandinavian journal of rheumatology | | | 2023 | 153 | 224 |
|
| A potential role for chlamydial infection in rheumatoid arthritis development | Rheumatology | | | 2023 | 98 | 286 |
|
| Comparison of drug retention of TNF inhibitors, other biologics and JAK inhibitors in RA patients who discontinued JAK inhibitor therapy | Rheumatology | | | 2023 | 89 | 277 |
|
| EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update | Annals of the rheumatic diseases | | | 2023 | 268 | 471 |
|
| Characterization of serum biomarkers and antibody responses against Prevotella spp. in preclinical and new-onset phase of rheumatic diseases | Frontiers in cellular and infection microbiology | | | 2023 | 120 | 211 |
|
| Brief report : assessment of mucosal barrier integrity using serological biomarkers in preclinical stages of rheumatoid arthritis | Frontiers in immunology | | | 2023 | 200 | 377 |
|
| Safety outcomes in patients with rheumatoid arthritis treated with abatacept: results from a multinational surveillance study across seven European registries | Arthritis research & therapy | | | 2023 | 73 | 198 |
|
| Impact of SARS-CoV2 infection on anti-apolipoprotein A-1 IgG response in inflammatory rheumatic diseases | Frontiers in immunology | | | 2023 | 137 | 105 |
|
| Management of giant-cell arteritis in Switzerland: an online national survey | Swiss medical weekly | | | 2023 | 236 | 552 |
|
| Omicron-specific cytotoxic t-cell responses after a third dose of mrna covid-19 vaccine among patients with multiple sclerosis treated with ocrelizumab | JAMA neurology | | | 2022 | 256 | 276 |
|
| EULAR points to consider when analysing and reporting comparative effectiveness research using observational data in rheumatology | Annals of the rheumatic diseases | | | 2022 | 216 | 85 |
|
| After JAK inhibitor failure: to cycle or to switch, that is the question – data from the JAK-pot collaboration of registries | Annals of the rheumatic diseases | | | 2022 | 274 | 579 |
|
| Nouveautés en médecine 2021 - Rhumatologie | Revue médicale suisse | | | 2022 | 302 | 287 |
|
| Accounting for missing data caused by drug cessation in observational comparative effectiveness research: a simulation study | Annals of the rheumatic diseases | | | 2022 | 300 | 145 |
|
| Periodontitis in first degree-relatives of individuals with rheumatoid arthritis: a short narrative review | Frontiers in oral health | | | 2022 | 210 | 143 |
|
| Prévention vaccinale chez les patients avec des maladies rhumatismales | Revue médicale suisse | | | 2022 | 119 | 178 |
|
| Lower odds of remission among women with rheumatoid arthritis: A cohort study in the Swiss Clinical Quality Management cohort | PloS one | | | 2022 | 77 | 104 |
|
| Combining individual patient data from randomized and non-randomized studies to predict real-world effectiveness of interventions | Statistical methods in medical research | | | 2022 | 157 | 142 |
|
| Global epidemiology of rheumatoid arthritis | Nature reviews. Rheumatology | | | 2022 | 403 | 1 |
|
| Robust T-Cell Responses in Anti-CD20 Treated Patients Following COVID-19 Vaccination: A Prospective Cohort Study | Clinical infectious diseases | | | 2022 | 246 | 217 |
|
| Effectiveness of TNF-inhibitors, abatacept, IL6-inhibitors and JAK-inhibitors in 31 846 patients with rheumatoid arthritis in 19 registers from the ‘JAK-pot’ collaboration | Annals of the rheumatic diseases | | | 2022 | 345 | 124 |
|
| Type of mRNA COVID-19 vaccine and immunomodulatory treatment influence humoral immunogenicity in patients with inflammatory rheumatic diseases | Frontiers in immunology | | | 2022 | 211 | 151 |
|
| Interruptions of biological and targeted synthetic disease-modifying antirheumatic drugs in rheumatoid arthritis : a descriptive cohort study assessing trends in patient characteristics in Switzerland | BMJ open | | | 2022 | 67 | 71 |
|
| Editoria : The interplay between the oral microbiota and rheumatoid arthritis | Frontiers in oral health | | | 2022 | 115 | 123 |
|
| Predictive value of anti-CarP and anti-PAD3 antibodies alone or in combination with RF and ACPA on the severity of rheumatoid arthritis | Rheumatology | | | 2021 | 384 | 578 |
|
| EULAR points to consider for the diagnosis and management of rheumatic immune-related adverse events due to cancer immunotherapy with checkpoint inhibitors | Annals of the Rheumatic Diseases | | | 2021 | 260 | 777 |
|
| Cohort profile: SCREEN-RA: design, methods and perspectives of a Swiss cohort study of first-degree relatives of patients with rheumatoid arthritis | BMJ Open | | | 2021 | 363 | 250 |
|
| Prediction of sustained biologic and targeted synthetic DMARD-free remission in rheumatoid arthritis patients | Rheumatology advances in practice | | | 2021 | 170 | 119 |
|
| Comparison of psoriatic arthritis and rheumatoid arthritis patients across body mass index categories in Switzerland | Journal of Clinical Medicine | | | 2021 | 230 | 130 |
|
| Identification of biological pathways specific to phases preceding rheumatoid arthritis development through gene expression profiling | International Journal of Immunogenetics | | | 2021 | 221 | 0 |
|
| Analysing and reporting of observational data: a systematic review informing the EULAR points to consider when analysing and reporting comparative effectiveness research with observational data in rheumatology | RMD open | | | 2021 | 271 | 183 |
|
| Impact of the COVID-19 pandemic on the disease course of patients with inflammatory rheumatic diseases: results from the Swiss Clinical Quality Management cohort | Annals of the Rheumatic Diseases | | | 2021 | 193 | 308 |
|
| Greater trochanteric pain syndrome: predicting who will respond to a local glucocorticoid injection | Scandinavian Journal of Rheumatology | | | 2021 | 266 | 0 |
|
| Associations between serum antibodies to periodontal pathogens and preclinical phases of rheumatoid arthritis | Rheumatology | | | 2021 | 268 | 0 |
|
| Primary and secondary non-response: in need of operational definitions in observational studies | Annals of the Rheumatic Diseases | | | 2021 | 258 | 118 |
|
| Influence of COVID-19 pandemic on decisions for the management of people with inflammatory rheumatic and musculoskeletal diseases: a survey among EULAR countries | Annals of the Rheumatic Diseases | | | 2021 | 215 | 392 |
|
| The impact of seropositivity on the effectiveness of biologic anti-rheumatic agents: results from a collaboration of 16 registries | Rheumatology | | | 2021 | 254 | 0 |
|
| Mazzotti reaction: Ivermectin-associated polyarthritis after delayed scabies treatment. Case report and review of the literature | Thérapie | | | 2021 | 1,175 | 1 |
|
| Cognitive-bias modification intervention to improve physical activity in patients following a rehabilitation programme: protocol for the randomised controlled IMPACT trial | BMJ open | | | 2021 | 258 | 317 |
|
| Impact of assessing patient-reported outcomes with mobile apps on patient–provider interaction | RMD Open | | | 2021 | 266 | 89 |
|
| Incidence of COVID-19 in patients treated with infliximab compared with patients treated with rituximab | RMD open | | | 2021 | 271 | 135 |
|
| Personalized prediction of disease activity in patients with rheumatoid arthritis using an adaptive deep neural network | PLOS ONE | | | 2021 | 303 | 260 |
|
| EULAR points to consider for conducting clinical trials and observational studies in individuals at risk of rheumatoid arthritis | Annals of the Rheumatic Diseases | | | 2021 | 380 | 139 |
|
| Is the prevention of rheumatoid arthritis possible? | Clinical Rheumatology | | | 2020 | 189 | 0 |
|
| Serum calprotectin: a promising biomarker in rheumatoid arthritis and axial spondyloarthritis | Arthritis Research and Therapy | | | 2020 | 420 | 617 |
|
| EULAR points to consider for the use of big data in rheumatic and musculoskeletal diseases | Annals of the Rheumatic Diseases | | | 2020 | 358 | 0 |
|
| Associations between gut microbiota and genetic risk for rheumatoid arthritis in the absence of disease: a cross-sectional study | The Lancet. Rheumatology | | | 2020 | 252 | 322 |
|
| smarter medicine: liste Top-5 pour le traitement des rhumatismes | Bulletin des médecins suisses | | | 2020 | 125 | 92 |
|
| EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update | Annals of the Rheumatic Diseases | | | 2020 | 494 | 356 |
|
| Measuring ACPA in the general population or primary care: is it useful? | RMD Open | | | 2020 | 246 | 238 |
|
| Mini-Review: Human Microbiome and Rheumatic Diseases | Frontiers in cellular and infection microbiology | | | 2020 | 200 | 264 |
|
| Preferences for treatments to prevent rheumatoid arthritis in Canada and the influence of shared decision-making | Clinical Rheumatology | | | 2020 | 213 | 0 |
|
| Predictive factors of treatment persistence in rheumatoid arthritis | Joint, Bone, Spine | | | 2020 | 436 | 761 |
|
| Comparative effectiveness of antitumour necrosis factor agents, biologics with an alternative mode of action and tofacitinib in an observational cohort of patients with rheumatoid arthritis in Switzerland | RMD Open | | | 2020 | 226 | 142 |
|
| Discordances between clinical and ultrasound measurements of disease activity among RA patients followed in real life | Joint, Bone, Spine | | | 2020 | 367 | 0 |
|
| The role of nutritional factors and intestinal microbiota in rheumatoid arthritis development | Nutrients | | | 2020 | 177 | 229 |
|
| Detection of circulating highly expanded T-cell clones in at-risk individuals for rheumatoid arthritis before the clinical onset of the disease | Rheumatology | | | 2020 | 337 | 9 |
|
| Periodontal status correlates with anti‐citrullinated protein antibodies in first‐degree relatives of individuals with rheumatoid arthritis | Journal of Clinical Periodontology | | | 2019 | 431 | 2 |
|
| Presence of anti-cyclic citrullinated peptide antibodies is associated with better treatment response to abatacept but not to TNF inhibitors in patients with rheumatoid arthritis: a meta-analysis | Clinical and Experimental Rheumatology | | | 2019 | 390 | 251 |
|
| Drug retention of biological DMARD in rheumatoid arthritis patients: the role of baseline characteristics and disease evolution | Rheumatology | | | 2019 | 380 | 0 |
|
| EULAR points to consider for the development, evaluation and implementation of mobile health applications aiding self-management in people living with rheumatic and musculoskeletal diseases | RMD Open | | | 2019 | 341 | 241 |
|
| Imputing missing data of function and disease activity in rheumatoid arthritis registers: what is the best technique? | RMD Open | | | 2019 | 341 | 168 |
|
| Menopause and possible effect on association between age and anticyclic citrullinated peptide antibodies in women at risk of rheumatoid arthritis | Journal of Rheumatology | | | 2019 | 307 | 0 |
|
| Synovitis in rheumatoid arthritis detected by grey scale ultrasound predicts the development of erosions over the next three years | Rheumatology | | | 2019 | 320 | 230 |
|
| Glucocorticoid injections for greater trochanteric pain syndrome: a randomised double-blind placebo-controlled (GLUTEAL) trial | Clinical Rheumatology | | | 2019 | 323 | 0 |
|
| The links of hepcidin and erythropoietin in the interplay of inflammation and iron deficiency in a large observational study of rheumatoid arthritis | British Journal of Haematology | | | 2019 | 264 | 0 |
|
| Role of reproductive and menopausal factors in functional and structural progression of rheumatoid arthritis: results from the SCQM cohort | Rheumatology | | | 2019 | 276 | 0 |
|
| 2018 EULAR recommendations for a core data set to support observational research and clinical care in giant cell arteritis | Annals of the Rheumatic Diseases | | | 2019 | 361 | 358 |
|
| Towards standardized patient reported physical function outcome reporting: linking ten commonly used questionnaires to a common metric | Quality of Life Research | | | 2019 | 278 | 177 |
|
| Patients with rheumatoid arthritis facing sick leave or work disability meet varying regulations: a study among rheumatologists and patients from 44 European countries | Annals of the Rheumatic Diseases | | | 2019 | 372 | 0 |
|
| Ultrasound is not associated with the presence of systemic autoimmunity or symptoms in individuals at risk for rheumatoid arthritis | RMD Open | | | 2019 | 345 | 161 |
|
| Preventing rheumatoid arthritis: preferences for and predicted uptake of preventive treatments among high risk individuals | PLOS ONE | | | 2019 | 313 | 285 |
|
| Current status of use of big data and artificial intelligence in RMDs: a systematic literature review informing EULAR recommendations | RMD Open | | | 2019 | 351 | 186 |
|
| Prevotella copri in individuals at risk for rheumatoid arthritis | Annals of the Rheumatic Diseases | | | 2019 | 474 | 0 |
|
| Preferences of Patients and At-risk Individuals for Preventive Approaches to Rheumatoid Arthritis | Clinical Therapeutics | | | 2019 | 302 | 1 |
|
| Intestinal dysbiosis in RA development: difficulty of establishing causality. Response to: 'Non-causal association of gut microbiome on the risk of rheumatoid arthritis: a Mendelian randomisation study' by Inamo | Annals of the Rheumatic Diseases | | | 2019 | 348 | 4 |
|
| Lessons learned from rheumatoid arthritis registries | Joint, Bone, Spine | | | 2018 | 451 | 3 |
|
| Initial validation and results of the Symptoms in Persons At Risk of Rheumatoid Arthritis (SPARRA) questionnaire: a EULAR project | RMD Open | | | 2018 | 469 | 204 |
|
| Workforce requirements in rheumatology: a systematic literature review informing the development of a workforce prediction risk of bias tool and the EULAR points to consider | RMD Open | | | 2018 | 329 | 269 |
|
| EULAR 'points to consider' for the conduction of workforce requirement studies in rheumatology | RMD Open | | | 2018 | 331 | 344 |
|
| Response to Tumor Necrosis Factor Inhibition in Male and Female Patients with Ankylosing Spondylitis: Data from a Swiss Cohort | Journal of Rheumatology | | | 2018 | 469 | 1 |
|
| Prediction of Real-World Drug Effectiveness Prelaunch: Case Study in Rheumatoid Arthritis | Medical Decision Making | | | 2018 | 482 | 0 |
|
| 2017 EULAR recommendations for a core data set to support observational research and clinical care in rheumatoid arthritis | Annals of the Rheumatic Diseases | | | 2018 | 436 | 0 |
|
| Microbiotes et rhumatismes inflammatoires | Revue médicale suisse | | | 2018 | 507 | 197 |
|
| Chagas disease and systemic autoimmune diseases among Bolivian patients in Switzerland | Memórias do Instituto Oswaldo Cruz | | | 2018 | 607 | 233 |
|
| Low Hemoglobin and Radiographic Damage Progression in Early Rheumatoid Arthritis: Secondary Analysis From a Phase III Trial | Arthritis Care and Research | | | 2018 | 373 | 1 |
|
| Incidence and prevalence of major adverse cardiovascular events in rheumatoid arthritis, psoriatic arthritis, and axial spondyloarthritis | Arthritis Care and Research | | | 2018 | 446 | 543 |
|
| Female hormonal factors and the development of anti-citrullinated protein antibodies in women at risk of rheumatoid arthritis | Rheumatology | | | 2017 | 564 | 5 |
|
| Risk of invasive melanoma in patients with rheumatoid arthritis treated with biologics: results from a collaborative project of 11 European biologic registers | Annals of the Rheumatic Diseases | | | 2017 | 509 | 298 |
|
| Value of Biomarkers in the Prevention of Rheumatoid Arthritis | Clinical Pharmacology and Therapeutics | | | 2017 | 467 | 0 |
|
| The prevalence of anticitrullinated protein antibodies increases with age in healthy individuals at risk for rheumatoid arthritis | Clinical Rheumatology | | | 2017 | 638 | 3 |
|
| EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update | Annals of the Rheumatic Diseases | | | 2017 | 489 | 2 |
|
| Does addition of glucocorticoids to the initial therapy influence the later course of the disease in patients with early RA? Results from the Swiss prospective observational registry (SCQM) | Clinical Rheumatology | | | 2017 | 415 | 0 |
|
| Presence of IL-17 in synovial fluid identifies a potential inflammatory osteoarthritic phenotype | PloS one | | | 2017 | 571 | 515 |
|
| Environmental factors and hormones in the development of rheumatoid arthritis | Seminars in Immunopathology | | | 2017 | 488 | 0 |
|
| Body mass does not impact the clinical response to intravenous abatacept in patients with rheumatoid arthritis. Analysis from the "pan-European registry collaboration for abatacept (PANABA) | Clinical Rheumatology | | | 2017 | 490 | 2 |
|
| The role of female hormonal factors in the development of rheumatoid arthritis | Rheumatology | | | 2017 | 476 | 0 |
|
| Differential impact of systemic lupus erythematosus and rheumatoid arthritis on health-related quality of life | Quality of life research | | | 2017 | 535 | 1 |
|
| New viral outbreaks: time for rheumatologists to get involved? | Rheumatology | | | 2017 | 469 | 0 |
|
| Impaired response to treatment with tumour necrosis factor α inhibitors in smokers with axial spondyloarthritis | Annals of the rheumatic diseases | | | 2016 | 604 | 0 |
|
| The Effect of Comedication With a Conventional Synthetic Disease-Modifying Antirheumatic Drug on Drug Retention and Clinical Effectiveness of Anti-Tumor Necrosis Factor Therapy in Patients With Axial Spondyloarthritis | Arthritis & rheumatology | | | 2016 | 539 | 0 |
|
| Points to consider for reporting, screening for and preventing selected comorbidities in chronic inflammatory rheumatic diseases in daily practice: a EULAR initiative | Annals of the Rheumatic Diseases | | | 2016 | 463 | 0 |
|
| Phase 1 Trials of rVSV Ebola Vaccine in Africa and Europe : Preliminary Report | The New England journal of medicine | | | 2016 | 943 | 317 |
|
| Low pre-treatment B-cell counts are not a risk factor of infection in patients treated with rituximab for autoimmune diseases: An observational study | Joint, Bone, Spine | | | 2016 | 542 | 0 |
|
| Preventive Treatments for Rheumatoid Arthritis: Issues Regarding Patient Preferences | Current rheumatology reports | | | 2016 | 569 | 1 |
|
| Brief Report: Association of Rheumatoid Factor and Anti-Citrullinated Protein Antibody Positivity With Better Effectiveness of Abatacept: Results From the Pan-European Registry Analysis | Arthritis and Rheumatology | | | 2016 | 391 | 0 |
|
| Rheumatoid Arthritis Patients after Initiation of a New Biologic Agent: Trajectories of Disease Activity in a Large Multinational Cohort Study | EBioMedicine | | | 2016 | 493 | 271 |
|
| Comparative Efficacy of Novel DMARDs as Monotherapy and in Combination with Methotrexate in Rheumatoid Arthritis Patients with Inadequate Response to Conventional DMARDs: A Network Meta-Analysis | Journal of managed care & specialty pharmacy | | | 2015 | 598 | 0 |
|
| Effectiveness of biologic DMARDs in monotherapy versus in combination with synthetic DMARDs in rheumatoid arthritis: data from the Swiss Clinical Quality Management Registry | Rheumatology | | | 2015 | 508 | 0 |
|
| The EULAR Study Group for Registers and Observational Drug Studies: comparability of the patient case mix in the European biologic disease modifying anti-rheumatic drug registers | Rheumatology | | | 2015 | 609 | 306 |
|
| The effect of dose on the safety and immunogenicity of the VSV Ebola candidate vaccine: a randomised double-blind, placebo-controlled phase 1/2 trial | Lancet. Infectious diseases | | | 2015 | 715 | 0 |
|
| The new 2010 ACR/EULAR criteria as predictor of clinical and radiographic response in patients with early arthritis | Clinical rheumatology | | | 2015 | 577 | 0 |
|
| An Internet-based technique for the identification of persons with symptoms of inflammatory polyarthritis of less than 12 weeks | Clinical rheumatology | | | 2015 | 484 | 0 |
|
| Anti-tumor necrosis factor drug survival in axial spondyloarthritis is independent of the classification criteria | Rheumatology international | | | 2015 | 609 | 0 |
|
| Chronic NSAID use and long-term decline of renal function in a prospective rheumatoid arthritis cohort study | Annals of the rheumatic diseases | | | 2015 | 660 | 0 |
|
| Rituximab versus an alternative TNF inhibitor in patients with rheumatoid arthritis who failed to respond to a single previous TNF inhibitor: SWITCH-RA, a global, observational, comparative effectiveness study | Annals of the rheumatic diseases | | | 2015 | 581 | 390 |
|
| The impact of patient heterogeneity and socioeconomic factors on abatacept retention in rheumatoid arthritis across nine European countries | RMD open | | | 2015 | 490 | 263 |
|
| Inflammatory Articular Disease in Patients with Inflammatory Bowel Disease: Result of the Swiss IBD Cohort Study | Inflammatory bowel diseases | | | 2015 | 504 | 0 |
|
| The impact of obesity on the development and progression of rheumatoid arthritis | Annals of the rheumatic diseases | | | 2014 | 573 | 0 |
|
| Immune-mediated experimental arthritis in IL-33 deficient mice | Cytokine | | | 2014 | 684 | 0 |
|
| Prevention of rheumatic diseases: strategies, caveats, and future directions | Rheumatic diseases clinics of North America | | | 2014 | 502 | 0 |
|
| Adipokines correlate with pain in lower limb osteoarthritis: different associations in hip and knee | International orthopaedics | | | 2014 | 591 | 0 |
|
| Tocilizumab in the treatment of rheumatoid arthritis: a cost-effectiveness analysis in the UK | PharmacoEconomics | | | 2014 | 542 | 537 |
|
| Joint damage progression in patients with rheumatoid arthritis in clinical remission. Do biologics perform better than synthetic antirheumatic drugs? | Journal of rheumatology | | | 2014 | 535 | 0 |
|
| Facteurs de risque pour le développement d'une polyarthrite rhumatoïde | Revue médicale suisse | | | 2014 | 543 | 2 |
|
| Anaemia may add information to standardised disease activity assessment to predict radiographic damage in rheumatoid arthritis: a prospective cohort study | Annals of the rheumatic diseases | | | 2014 | 625 | 629 |
|
| Persistence of ultrasound synovitis in patients with rheumatoid arthritis fulfilling the DAS28 and/or the new ACR/EULAR RA remission definitions: results of an observational cohort study | Joint bone spine | | | 2014 | 603 | 0 |
|
| Methotrexate in chronic-recurrent calcium pyrophosphate deposition disease: no significant effect in a randomized crossover trial | Arthritis research & therapy | | | 2014 | 715 | 291 |
|
| Complications cardio-vasculaires dans les maladies auto-immunes | Revue médicale suisse | | | 2013 | 555 | 1 |
|
| Disease activity in rheumatoid arthritis patients at initiation of biologic agents and 1 year of treatment: results from the Swiss SCQM registry | Joint bone spine | | | 2013 | 569 | 0 |
|
| Disease severity in K/BxN serum transfer-induced arthritis is not affected by IL-33 deficiency | Arthritis research & therapy | | | 2013 | 655 | 313 |
|
| Primary prevention of rheumatoid arthritis: a qualitative study in a high-risk population | Joint bone spine | | | 2013 | 636 | 1 |
|
| Do synovial leptin levels correlate with pain in end stage arthritis? | International orthopaedics | | | 2013 | 686 | 281 |
|
| Smoking and spondyloarthritis | Joint bone spine | | | 2013 | 574 | 1 |
|
| The importance of early treatment for the prognosis of rheumatoid arthritis | Schweizerische medizinische Wochenschrift | | | 2013 | 666 | 341 |
|
| Adalimumab in acute sciatica reduces the long-term need for surgery: a 3-year follow-up of a randomised double-blind placebo-controlled trial | Annals of the rheumatic diseases | | | 2012 | 684 | 0 |
|
| Evolution of radiographic joint damage in rituximab-treated versus TNF-treated rheumatoid arthritis cases with inadequate response to TNF antagonists | Annals of the rheumatic diseases | | | 2012 | 575 | 448 |
|
| Evaluation of cardiovascular risk in patients with rheumatoid arthritis: do cardiovascular biomarkers offer added predictive ability over established clinical risk scores? | Arthritis care & research | | | 2012 | 707 | 0 |
|
| Pain as an important predictor of psychosocial health in patients with rheumatoid arthritis | Arthritis care & research | | | 2012 | 675 | 0 |
|
| EULAR recommendations for terminology and research in individuals at risk of rheumatoid arthritis: report from the Study Group for Risk Factors for Rheumatoid Arthritis | Annals of the rheumatic diseases | | | 2012 | 710 | 598 |
|
| Differential drug retention between anti-TNF agents and alternative biological agents after inadequate response to an anti-TNF agent in rheumatoid arthritis patients | Annals of the rheumatic diseases | | | 2012 | 689 | 0 |
|
| Spontaneous secretion of interleukin-17 and -22 by human cervical cells in Chlamydia trachomatis infection | Microbes and infection | | | 2011 | 625 | 0 |
|
| Patient repositioning reproducibility of joint space with (JSW) measurements on hand radiographs | Arthritis care & research | | | 2011 | 497 | 0 |
|
| Symptomatic effects of chondroitin 4 and chondroitin 6 sulfate on hand osteoarthritis: a randomized, double-blind, placebo-controlled clinical trial at a single center | Arthritis and rheumatism | | | 2011 | 697 | 0 |
|
| The long-term impact of early treatment of rheumatoid arthritis on radiographic progression: a population-based cohort study | Rheumatology | | | 2011 | 618 | 0 |
|
| Autoimmunity and inflammation are independent of class II transactivator type PIV-dependent class II major histocompatibility complex expression in peripheral tissues during collagen-induced arthritis | Arthritis and rheumatism | | | 2011 | 657 | 0 |
|
| Do new biologics meet the unmet medical need in rheumatoid arthritis? Safety and efficacy of abatacept following B-cell depletion | Rheumatology | | | 2011 | 518 | 0 |
|
| Indirect comparisons of the efficacy of biological antirheumatic agents in rheumatoid arthritis in patients with an inadequate response to conventional disease-modifying antirheumatic drugs or to an anti-tumour necrosis factor agent: a meta-analysis | Annals of the rheumatic diseases | | | 2011 | 603 | 0 |
|
| EULAR points to consider when establishing, analysing and reporting safety data of biologics registers in rheumatology | Annals of the rheumatic diseases | | | 2010 | 602 | 0 |
|
| Osteoarthritis: Small studies overestimate the benefit of therapies for OA | Nature reviews. Rheumatology | | | 2010 | 697 | 0 |
|
| Influence of anti-infliximab antibodies and residual infliximab concentrations on the occurrence of acquired drug resistance to infliximab in rheumatoid arthritis patients | Joint bone spine | | | 2010 | 627 | 0 |
|
| Diagnostic value of anti-cyclic citrullinated peptides and association with HLA-DRB1 shared epitope alleles in African rheumatoid arthritis patients | Arthritis research & therapy | | | 2010 | 802 | 605 |
|
| Anti-apolipoprotein A-1 IgG predicts major cardiovascular events in patients with rheumatoid arthritis | Arthritis and rheumatism | | | 2010 | 920 | 3 |
|
| Cost-effectiveness of biologics in early rheumatoid arthritis | Annals of internal medicine | | | 2010 | 533 | 0 |
|
| The effect of alcohol on radiographic progression in rheumatoid arthritis | Arthritis and rheumatism | | | 2010 | 607 | 0 |
|
| Which subgroup of patients with rheumatoid arthritis benefits from switching to rituximab versus alternative anti-tumour necrosis factor (TNF) agents after previous failure of an anti-TNF agent? | Annals of the rheumatic diseases | | | 2010 | 608 | 0 |
|
| Comparative effectiveness of rheumatoid arthritis therapies | Current rheumatology reports | | | 2010 | 539 | 0 |
|
| Swiss consensus statement: Recommendations for optimising re-treatment with MabThera (rituximab) in rheumatoid arthritis | Schweizerische medizinische Wochenschrift | | | 2010 | 577 | 0 |
|
| A comparison of patient characteristics and outcomes in selected European and U.S. rheumatoid arthritis registries | Seminars in arthritis and rheumatism | | | 2010 | 641 | 0 |
|
| Adalimumab in severe and acute sciatica: a multicenter, randomized, double-blind, placebo-controlled trial | Arthritis and rheumatism | | | 2010 | 684 | 0 |
|
| Inhibition of interleukin-33 signaling attenuates the severity of experimental arthritis | Arthritis and rheumatism | | | 2009 | 667 | 0 |
|
| Clinical experience with mycophenolate mofetil in systemic autoimmune conditions refractory to common immunosuppressive therapies | Schweizerische medizinische Wochenschrift | | | 2009 | 643 | 498 |
|
| Comparison of drug retention rates and causes of drug discontinuation between anti-tumor necrosis factor agents in rheumatoid arthritis | Arthritis and rheumatism | | | 2009 | 643 | 0 |
|
| BMI and severity of clinical and radiographic signs of hip osteoarthritis | Obesity | | | 2009 | 999 | 0 |
|
| Influence of cytokine inhibitors on concentration and activity of MMP-1 and MMP-3 in disc herniation | Arthritis research & therapy | | | 2009 | 675 | 291 |
|
| The effectiveness of leflunomide as a co-therapy of tumour necrosis factor inhibitors in rheumatoid arthritis: a population-based study | Annals of the rheumatic diseases | | | 2009 | 623 | 0 |
|
| Elevated levels of tumor necrosis factor-alpha in periradicular fat tissue in patients with radiculopathy from herniated disc | Spine | | | 2008 | 688 | 0 |
|
| At the horizon of innovative therapy in rheumatology: new biologic agents | Current opinion in rheumatology | | | 2008 | 638 | 0 |
|
| Primer: strengths and weaknesses of meta-analysis | Nature clinical practice rheumatology | | | 2008 | 683 | 0 |
|
| Neutral functional realignment orthosis prevents hand pain in patients with subacute stroke: a randomized trial | Archives of physical medicine and rehabilitation | | | 2008 | 618 | 0 |
|
| B cell depletion may be more effective than switching to an alternative anti-tumor necrosis factor agent in rheumatoid arthritis patients with inadequate response to anti-tumor necrosis factor agents | Arthritis and rheumatism | | | 2007 | 185 | 1 |
|
| Occupational silica and solvent exposures and risk of systemic lupus erythematosus in urban women | Arthritis and rheumatism | | | 2006 | 256 | 740 |
|
| Fibromyalgia: a randomised, controlled trial of a treatment programme based on self management | Annals of the rheumatic diseases | | | 2004 | 517 | 2 |
|
| Neurophysiologic evidence for a central sensitization in patients with fibromyalgia | Arthritis and rheumatism | | | 2003 | 557 | 1,066 |
|
